Citizens JMP analyst Jonathan Wolleben downgraded Rallybio Corp. (NASDAQ: RLYB) from Market Outperform to Market Perform.The analyst comments "Rallybio is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE